<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: lamotrigine</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Fetal exposure to antiepileptic drug valproate impairs cognitive development</title>
   	 <description>(Medical Xpress)—The effects of antiepileptic drugs during pregnancy have long been a concern of clinicians and women of childbearing age whose seizures can only be controlled by medications. In 1999, a study called the Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) began following the children of women who were taking a single antiepileptic agent during pregnancy. The drugs included carbamazepine, lamotrigine, phenytoin or valproate.</description>
     <link>http://medicalxpress.com/news/2013-03-fetal-exposure-antiepileptic-drug-valproate.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 20 Mar 2013 07:18:02 EST</pubDate>
	 <guid isPermaLink="false">news282982655</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/fetalexposur.jpg" width="90" height="90" />
</item>
<item>
     <title>Exposure to antiepileptic drug in womb linked to autism risk</title>
   	 <description>Children whose mothers take the antiepileptic drug sodium valproate while pregnant are at significantly increased risk of autism and other neurodevelopmental disorders, suggests a small study published online in the Journal of Neurology Neurosurgery and Psychiatry.</description>
     <link>http://medicalxpress.com/news/2013-01-exposure-antiepileptic-drug-womb-linked.html</link>
	 <category>Autism spectrum disorders</category>
	 <pubDate>Wed, 30 Jan 2013 18:30:01 EST</pubDate>
	 <guid isPermaLink="false">news278789774</guid>
	 
</item>
<item>
     <title>Perampanel for epilepsy: No proof of added benefit</title>
   	 <description>The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive (&quot;add-on&quot;) therapy for adults and children aged 12 years and older with epileptic fits (seizures). In an early benefit assessment according to the German Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether perampanel offers an added benefit over the previous standard therapy. However, no such added benefit can be derived from the dossier, because the manufacturer failed to present any relevant data in it for the comparison with the drugs lamotrigine or topiramate.</description>
     <link>http://medicalxpress.com/news/2013-01-perampanel-epilepsy-proof-added-benefit.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 30 Jan 2013 09:38:36 EST</pubDate>
	 <guid isPermaLink="false">news278761110</guid>
	 
</item>
<item>
     <title>Study reveals long-term effects on child IQ of epilepsy drug valproate during pregnancy</title>
   	 <description>Research published today in the Lancet Neurology shows that taking the antiepileptic drug valproate during pregnancy affects the IQ of children up to the age of six.</description>
     <link>http://medicalxpress.com/news/2013-01-reveals-long-term-effects-child-iq.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 22 Jan 2013 18:30:02 EST</pubDate>
	 <guid isPermaLink="false">news278098291</guid>
	 
</item>
<item>
     <title>Study raises questions about use of anti-epilepsy drugs in newborns</title>
   	 <description>A brain study in infant rats demonstrates that the anti-epilepsy drug phenobarbital stunts neuronal growth, which could prompt new questions about using the first-line drug to treat epilepsy in human newborns.</description>
     <link>http://medicalxpress.com/news/2012-05-anti-epilepsy-drugs-newborns.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Fri, 11 May 2012 11:36:14 EST</pubDate>
	 <guid isPermaLink="false">news255954965</guid>
	 
</item>
<item>
     <title>Study finds superior drug combo for difficult-to-control epilepsy</title>
   	 <description>A combination of two common drugs, lamotrigine and valproate, is more effective in treating difficult-to control epilepsy than other anti-epileptic regimens, according to a University of Washington report to be published online this week in Neurology, the journal of the American Academy of Neurology.</description>
     <link>http://medicalxpress.com/news/2011-12-superior-drug-combo-difficult-to-control-epilepsy.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Wed, 14 Dec 2011 16:20:12 EST</pubDate>
	 <guid isPermaLink="false">news243102003</guid>
	 
</item>
<item>
     <title>A more ethical way to compare epilepsy treatments</title>
   	 <description>For the first time, a new research methodology recently approved by the Food and Drug Administration has been used to demonstrate that converting patients from one anti-epileptic drug to another - in this case, lamotrigine extended-release (LTG XR) - is well-tolerated, effective and safe. The work by Jacqueline French and her team, from New York University in the US, illustrates how the new methodology addresses ethical issues inherent in more traditional study designs. It is published online in Springer's journal, Neurotherapeutics.</description>
     <link>http://medicalxpress.com/news/2011-12-ethical-epilepsy-treatments.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Mon, 05 Dec 2011 13:19:48 EST</pubDate>
	 <guid isPermaLink="false">news242313386</guid>
	 
</item>
<item>
     <title>Prenatal use of newer antiepileptic drugs not associated with increased risk of major birth defects</title>
   	 <description>Use of newer-generation antiepileptic drugs, which are also prescribed for bipolar mood disorders and migraine headaches, during the first trimester of pregnancy was not associated with an increased risk of major birth defects in the first year of life among infants in Denmark, according to a study in the May 18 issue of JAMA. Older-generation antiepileptic drugs are associated with an increased risk of birth defects.</description>
     <link>http://medicalxpress.com/news/2011-05-prenatal-antiepileptic-drugs-major-birth.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 17 May 2011 16:58:24 EST</pubDate>
	 <guid isPermaLink="false">news224870293</guid>
	 
</item>


</channel>
</rss>
